TipRanks
Medlive Technology Co., Ltd. (HK:2192)
:2192
Hong Kong Market
2192
Medlive Technology Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:2192 full AI Analyst Report?

Medlive Technology Co., Ltd. (2192) Ratios

1 Followers

Medlive Technology Co., Ltd. Ratios

HK:2192's free cash flow for Q2 2026 was ¥0.62. For the 2026 fiscal year, HK:2192's free cash flow was decreased by ¥ and operating cash flow was ¥0.28. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 16.37 19.09 21.03 24.10 32.78
Quick Ratio
 16.37 19.09 21.03 24.09 32.78
Cash Ratio
 8.84 12.28 18.56 22.97 31.54
Solvency Ratio
 1.83 1.49 1.26 1.01 0.74
Operating Cash Flow Ratio
 1.52 0.64 0.52 0.54 0.58
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 2.75B¥ 3.76B¥ 4.10B¥ 4.32B¥ 4.18B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.05 1.06 1.06 1.06 1.05
Debt Service Coverage Ratio
 377.51 294.55 141.45 724.35 256.01
Interest Coverage Ratio
 253.93 166.44 68.25 54.91 28.56
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 0.01 0.03 0.01 0.02
Net Debt to EBITDA
 -8.07 -14.62 -31.50 -16.55 -28.89
Profitability Margins
Gross Profit Margin
61.31%60.02%58.59%61.00%67.74%
EBIT Margin
29.24%26.06%21.03%61.53%43.17%
EBITDA Margin
30.35%27.25%21.73%63.80%46.03%
Operating Profit Margin
18.68%14.31%9.61%4.81%4.83%
Pretax Profit Margin
57.63%56.11%60.97%61.44%43.00%
Net Profit Margin
52.77%52.07%56.43%58.81%37.36%
Continuous Operations Profit Margin
55.06%54.18%59.15%61.11%40.25%
Net Income Per EBT
91.56%92.80%92.56%95.72%86.88%
EBT Per EBIT
308.53%392.16%634.66%1277.09%890.28%
Return on Assets (ROA)
6.75%6.48%6.17%4.95%2.55%
Return on Equity (ROE)
7.05%6.87%6.57%5.27%2.67%
Return on Capital Employed (ROCE)
2.48%1.86%1.09%0.42%0.34%
Return on Invested Capital (ROIC)
2.37%1.79%1.06%0.42%0.32%
Return on Tangible Assets
7.11%6.83%6.51%5.18%2.63%
Earnings Yield
8.38%5.21%4.59%4.56%2.18%
Efficiency Ratios
Receivables Turnover
 2.50 2.53 3.08 2.64 2.53
Payables Turnover
 6.74 11.52 16.68 10.88 37.40
Inventory Turnover
 0.00 0.00 0.00 1.62K 509.11
Fixed Asset Turnover
 25.18 19.51 14.68 37.20 21.55
Asset Turnover
 0.13 0.12 0.11 0.08 0.07
Working Capital Turnover Ratio
 0.20 0.16 0.13 0.10 0.08
Cash Conversion Cycle
 91.98 112.47 96.65 104.80 135.32
Days of Sales Outstanding
 146.16 144.16 118.53 138.13 144.36
Days of Inventory Outstanding
 0.00 0.00 0.00 0.22 0.72
Days of Payables Outstanding
 54.18 31.69 21.88 33.56 9.76
Operating Cycle
 146.16 144.16 118.53 138.36 145.08
Cash Flow Ratios
Operating Cash Flow Per Share
 0.37 0.18 0.15 0.14 0.11
Free Cash Flow Per Share
 0.37 0.17 0.12 0.09 0.10
CapEx Per Share
 <0.01 0.02 0.03 0.04 0.01
Free Cash Flow to Operating Cash Flow
 0.99 0.90 0.81 0.68 0.90
Dividend Paid and CapEx Coverage Ratio
 1.42 0.68 0.54 0.65 3.93
Capital Expenditure Coverage Ratio
 128.74 10.48 5.19 3.13 10.31
Operating Cash Flow Coverage Ratio
 42.52 13.30 4.79 12.43 6.85
Operating Cash Flow to Sales Ratio
 0.42 0.21 0.19 0.25 0.25
Free Cash Flow Yield
6.66%1.90%1.27%1.30%1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.96 19.36 21.77 21.95 45.86
Price-to-Sales (P/S) Ratio
 6.31 10.00 12.28 12.91 17.13
Price-to-Book (P/B) Ratio
 0.85 1.32 1.43 1.16 1.22
Price-to-Free Cash Flow (P/FCF) Ratio
 15.01 52.74 78.46 76.69 77.20
Price-to-Operating Cash Flow Ratio
 14.87 47.71 63.34 52.20 69.71
Price-to-Earnings Growth (PEG) Ratio
 2.63 4.16 0.72 0.21 0.32
Price-to-Fair Value
 0.85 1.32 1.43 1.16 1.22
Enterprise Value Multiple
 12.73 22.06 25.04 3.68 8.34
Enterprise Value
 2.49B 3.86B 3.04B 967.29M 1.20B
EV to EBITDA
 12.73 22.06 25.04 3.68 8.34
EV to Sales
 3.86 6.01 5.44 2.35 3.84
EV to Free Cash Flow
 9.19 31.72 34.75 13.95 17.29
EV to Operating Cash Flow
 9.12 28.70 28.05 9.50 15.61
Tangible Book Value Per Share
 6.23 6.34 6.23 6.02 6.01
Shareholders’ Equity Per Share
 6.50 6.60 6.52 6.26 6.16
Tax and Other Ratios
Effective Tax Rate
 0.04 0.03 0.03 <0.01 0.06
Revenue Per Share
 0.87 0.87 0.76 0.56 0.44
Net Income Per Share
 0.46 0.45 0.43 0.33 0.16
Tax Burden
 0.92 0.93 0.93 0.96 0.87
Interest Burden
 1.97 2.15 2.90 1.00 1.00
Research & Development to Revenue
 0.10 0.12 0.12 0.00 0.15
SG&A to Revenue
 0.32 0.34 0.37 0.35 0.39
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.01 0.03 0.05
Income Quality
 0.81 0.37 0.32 0.40 0.57
Currency in CNY